Ceramide Signaling and Metabolism in Pathophysiological States of the Lung.

Ceramide Signaling and Metabolism in Pathophysiological States of the Lung.

Item
http://www.wikidata.org/entity/Q38669199
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget.C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells.Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.Lipidomic dysregulation within the lung parenchyma following whole-thorax lung irradiation: Markers of injury, inflammation and fibrosis detected by MALDI-MSI.Neutrophil elastase increases airway ceramide levels via upregulation of serine palmitoyltransferase.S1PR3 Signaling Drives Bacterial Killing and Is Required for Survival in Bacterial Sepsis.Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency.Distinct Serum Sphingolipid Profiles among School-aged Children with Exercise-induced Wheeze and Asthma Persistence.Sphingolipid regulation of lung epithelial cell mitophagy and necroptosis during cigarette smoke exposure.
P2860

Ceramide Signaling and Metabolism in Pathophysiological States of the Lung.

Item
http://www.wikidata.org/entity/Q38669199
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ceramide Signaling and Metabolism in Pathophysiological States of the Lung.
@en
type
label
Ceramide Signaling and Metabolism in Pathophysiological States of the Lung.
@en
prefLabel
Ceramide Signaling and Metabolism in Pathophysiological States of the Lung.
@en
P1433
P1476
P2093
P304
P31
P356
P478
P577
P698
P921
P356
P1433
P1476
Ceramide Signaling and Metabolism in Pathophysiological States of the Lung.
@en
P2093
P304
P31
P356
10.1146/ANNUREV-PHYSIOL-021115-105221
P478
P577
P698
P921